Field Access Senior Manager
No salary listed
Expert
Bachelor's, Master's, MBA
Mexico
In PersonNational travel of 50% to 60%.
Sales & Account ManagementAccount Management
About the job
Requirements
- A completed and titled undergraduate degree in health sciences, chemical-biological sciences, administration, economics, or a related field.
- At least 10 years of experience in the pharmaceutical industry.
- At least 5 years of experience in institutional access or the government channel in Mexico, with direct responsibility for supply and supply orders.
- At least 3 years of experience leading field teams.
- Demonstrated experience aligning commercial teams, converting demand into institutional purchases, and mapping patient journeys in public institutions.
- Knowledge of budgets and decision-making processes for IMSS, IMSS-Bienestar, ISSSTE, state services, OPDs, and armed forces and parastatal systems.
- Knowledge of institutional access routes, including the National Compendium before the General Health Council, specific-patient purchases, institutional committees, the IMSS Control Tower, and the PEPMAE workflow.
- Knowledge of the Public Sector Acquisitions, Leases and Services Law, consolidated purchasing, tenders, and open contracts.
- Knowledge of contracts, supply orders, inventories, and penalties.
- Knowledge of demand forecasting, sales and operations planning, customer relationship management, and business intelligence dashboards.
- Native Spanish and advanced English are indispensable for interaction with LATAM and Worldwide.
- Ability to travel nationally 50% to 60%.
- Skills in leadership and talent development, urgency and resolution, strategic thinking with operational execution, data-driven decision-making, influence without authority, adaptability, integrity, and ethical judgment.
Responsibilities
- Ensure continuous supply and timely access to the BMS portfolio at major Mexican healthcare institutions, leading the field team of Field Access Managers and Key Account Managers.
- Ensure products remain available across IMSS Ordinario, IMSS-Bienestar, ISSSTE, high-specialty hospitals, OPDs, and state services, preventing treatment interruptions for patients already in care.
- Maintain visibility into inventory at central warehouses, delegational warehouses, and medical units; anticipate shortages or excess inventory and activate contingency plans until supply is normalized.
- Coordinate escalation of supply incidents with Supply Chain, Customer Service, Finance, Commercial, and authorized distributors, with defined response times.
- Report institutional service levels, root causes, and action plans for significant incidents to the Market Access Director.
- Ensure accurate, timely issuance and fulfillment of all national supply orders across all portfolio brands.
- Reconcile each order against the current contract or allocation, actual demand at the medical unit, and available inventory.
- Resolve pending orders, partial deliveries, fulfillment discrepancies, penalties, and credit notes.
- Maintain the national order dashboard and provide consumption information for demand forecasting and sales and operations planning.
- Align business units, Marketing, TAS, and the sales force with institution-, molecule-, and indication-level access strategies and consistent customer priorities.
- Convert generated demand into institutional purchases by connecting prescriptions with the applicable access route, available budget, and corresponding supply order.
- Lead weekly operational reviews and monthly business reviews with the commercial team, documenting agreements and accountable owners.
- Track the full demand-to-treatment cycle, intervene when the process stalls, and close gaps between expected demand and actual consumption.
- Ensure specific-patient purchase requests are compiled, submitted, tracked, and approved within deadlines to prevent treatment delays or interruptions.
- Ensure timely incorporation of new approved indications, including institutional catalog inclusion, budget allocation, and clinical-administrative authorizations.
- Govern submissions to Pharmacy and Therapeutics Committees and other institutional bodies, including controlled-prescription cases outside the National Compendium.
- Manage and track required authorizations through the IMSS Control Tower for new indications, ensuring complete submissions and timely resolution of observations.
- Ensure correct submission and follow-up of cases in the PEPMAE platform in coordination with the central-level Key Account Manager.
- Set target resolution times by process and institution, manage a case escalation dashboard, and improve documentation quality to reduce rejections and rework.
- Systematically oversee each Field Access Manager's work on institutional patient journeys, using aggregated process-level analysis without accessing personally identifiable patient information or influencing clinical decisions.
- Ensure each Field Access Manager maintains an updated institutional patient journey covering suspected diagnosis, referral, confirmation and biomarkers, evaluation, prescription, authorization route, fulfillment, administration, and continuity.
- Identify bottlenecks and patient drop-off at each stage, and track institutional and molecule-level funnels from eligible and diagnosed through prescribed, authorized, treated, and continuing patients.
- Monitor and reduce time from diagnosis to first dose and from prescription to institutional authorization.
- Prevent treatment interruptions caused by expiring authorizations, exhausted budgets, lack of replenishment, or cycle timing, and anticipate renewals.
- Develop plans with Medical Affairs, Marketing, PSP, and business units to address critical patient-journey stages, and hold recurring documented reviews with each Field Access Manager.
- Lead and develop 8 Field Access Managers and 4 Key Account Managers, establishing clear and measurable objectives, priorities, and execution standards.
- Conduct structured field coaching with documented visits and manage the performance cycle, including objectives, reviews, calibration, and improvement plans.
- Ensure onboarding and enablement for the team under the new Field Access Manager job description.
- Optimize territorial coverage, routes, and account assignments, and model BMS's culture of integrity, collaboration, and patient focus.
- Translate the access strategy into a national field plan with account segmentation and prioritization, and lead quarterly account-planning reviews.
- Ensure launch readiness for new immuno-oncology indications planned for 2026 and 2027, and monitor launch-access milestones, including the first institutional patient, enabled medical units, allocated budget, and catalog inclusion.
- Coordinate field stakeholder mapping and execution with HEOR & Value Access, Medical Affairs, and Corporate Affairs.
- Represent Field Access in 3M forums and brand teams, contributing institutional-customer and patient perspectives.
- Coordinate tender, contract, and commercial-condition execution with Government & Private Sales, Gov. Tender Sr Manager, and Specialist Contract Management.
- Communicate field evidence needs to HEOR & Value Access, ensure effective use of generated tools, and coordinate patient-support pathways with PSP.
- Define, monitor, and communicate team metrics, ensuring disciplined use of the CRM and supply, order, and case dashboards.
- Manage the team's operating budget in accordance with spending policies and maintain complete documentation for each case file and recorded interaction.
Desired Qualifications
- A postgraduate qualification such as an MBA, public health, or health economics.
- Experience launching specialty products in oncology, hematology, or immunology.
About the company
Bristol Myers Squibb discovers, develops and sells prescription medicines for serious illnesses, including cancer, blood disorders, immune diseases and heart disease, for patients treated by doctors and hospitals around the world. Its best-known drug is Opdivo, an immunotherapy that helps the body's own immune system find and attack many kinds of cancer. Researchers develop drug candidates in its labs or bring them in through acquisitions and partnerships, then test them in clinical trials to win regulatory approval. The company makes and markets the approved medicines and earns its revenue from sales of patent-protected drugs. Its roots go back to a business founded in 1887, and it is based in Lawrence Township, New Jersey.
Company Size
10,001+
Company Stage
IPO
Headquarters
Lawrence Township, New Jersey
Founded
1887
Get referred to Bristol Myers Squibb
See people who can refer or advise you
Simplify's Take
What believers are saying
- Sales are beating forecasts: BMS raised 2026 revenue guidance to $49 billion to $50 billion in July 2026.
- Newer drugs carry the business: they made $7.6 billion of $13.0 billion in sales in the June 2026 quarter.
- Manufacturing careers are expanding: a $2.3 billion Houston campus announced in August 2026 will add nearly 500 skilled roles.
What critics are saying
- Job security is shaky: BMS added 265 New Jersey layoffs in September 2026, bringing its 2026 state cuts to 718.
- A patent cliff looms: Eliquis and Opdivo, its two biggest drugs, lose US exclusivity around 2028.
- Older drugs are shrinking fast: Revlimid sales fell 49% to $425 million in the June 2026 quarter as generics spread.
What makes Bristol Myers Squibb unique
- BMS owns a psychiatry first: Cobenfy treats schizophrenia without blocking dopamine, unlike antipsychotics used for decades.
- Its top seller is shared: BMS splits Eliquis blood thinner profits roughly equally with Pfizer in most markets.
- BMS reengineers patients' own immune cells: it sells two CAR T therapies, Breyanzi and Abecma, for blood cancers.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Flexible Work Hours
- Hybrid Work Options
- Professional Development Budget